FDA
-
-
-
-
-
-
-
Zura Bio Ltd. (ZURA) PT Lowered to $3 at H.C. Wainwright
-
-
-
-
-
-
-
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
-
-
-
329,911 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

